More articles from Center for Therapy Excellence Young Investigator Award Session

You have access
Progression and toxicity following liver Y90 radioembolization: impact of dose metrics, clinical factors, and biomarkers
Theresa Devasia, Matthew Cousins, Justin Mikell, Ravi Kaza, Matthew Schipper, Kyle Cuneo and Yuni Dewaraja

Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 21;
You have access
Role of ⁶⁸Ga-fibroblast activation protein inhibitor (FAPI) PET/CT in the evaluation of peritoneal carcinomatosis and comparison with ¹⁸F-FDG PET/CT
Haojun Chen, Liang Zhao, Yizhen Pang, Long Sun and Hua Wu

Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 20;
You have access
Can absorbed radiation doses by organs and tumors after PRRT be estimated from a single SPECT/CT study?
Alexandre Chicheportiche, Moshe Sason, Yodphat Krausz, Jeremy Godefroy, Simona Grozinsky-Glasberg, Kira Oleinikov, Amichay Meirovitz, David Gross and Simona Ben-Haim

Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 18;
You have access
⁶⁸Ga-PSMA PET/CT for response assessment and outcome prediction in metastatic prostate cancer undergoing taxane-based chemotherapy
Qaid Shagera, Carlos Artigas, Spyridon Sideris, Nieves Martinez Chanza, Thierry Gil, Alexandre Peltier and Patrick Flamen

Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 15;
You have access
Metastatic Disease Response and Patterns of Recurrence in Men with High-Risk Prostate Cancer after Neo-Adjuvant Chemohormonal Therapy and Radical Prostatectomy utilizing PSMA-Targeted ¹⁸F-DCFPyL PET/CT
Petra Lovrec, Patrick Belson, Shane Wells, Christos Kyriakopoulos, Wei Huang, David Beebe, Joshua Lang, David Jarrard and Steve Cho

Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 17;
You have access
Long-term outcome of ²²⁵Ac-DOTATATE Targeted Alpha Therapy in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors
Chandrasekhar Bal, Sanjana Ballal and Madhav Yadav

Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 19;
You have access
Safety and efficacy of radioligand therapy with ¹⁷⁷lutetium-PSMA-617 within 3 months after ²²³Radium-dichloride
Justus Baumgarten, Daniel Groener, Christina Nguyen Ngoc, Nicolai Mader, Karen Davis, Philipp Mandel, Nikolaos Tselis, Christian Happel, Frank Gruenwald and Amir Sabet

Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 16;

Main menu

User menu

Search

More articles from Center for Therapy Excellence Young Investigator Award Session